United Kingdom· GB-APID-34592511000001100
Cystadrops 3.8mg/ml eye drops
A mercaptamine product containing mercaptamine, registered in United Kingdom by Recordati Rare Diseases UK Ltd. The same ATC class is registered in 13 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Mercaptamine is registered in 13 of 19 countries.
Countries holding a registration under ATC S01XA21 (mercaptamine), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 7 of them publish a price we can compare per daily dose
Mercaptamine · ATC S01XA21
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Mercaptamine
- Manufacturer
- Recordati Rare Diseases UK Ltd
- Country
- United Kingdom (GB)
- ATC code
- S01XA21
- ATC class
- Mercaptamine
- Defined daily dose
- 0.4 ml, AT
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin3663502000588
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Mercaptamine in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesCYSTADROPSRECORDATI RARE DISEASES, INC.
- CzechiaCYSTADROPSRecordati Rare Diseases, Puteaux
- IrelandCystadrops 3.8 mg/mL eye drops solutionRecordati Rare Diseases
- PolandCystadropsRecordati Rare Diseases
- SwedenCystadrops 3,8 mg/ml Ögondroppar, lösningRecordati Rare Diseases
- FinlandCystadropsRecordati Rare Diseases
- BelgiumCystadrops 3.8 mg/mlRecordati Rare Diseases
- IcelandCYSTADROPSRecordati Rare Diseases*
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Cystadrops, Cystagon
- Liechtenstein · Cystadrops, Cystagon
- Norway · Cystadrops, Cystagon
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/67840c23-78ab-49d1-bcdb-75def7aaa5f6 GET /v1/drugs/67840c23-78ab-49d1-bcdb-75def7aaa5f6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "34592511000001100",
"desc": "Cystadrops 3.8mg/ml eye drops (Recordati Rare Diseases UK Ltd)",
"form": "Eye drops",
"vpid": "34607111000001102",
"source": "dmd",
"vtm_id": "776687008",
"strength": "3.8 mg",
"substance": "Mercaptamine",
"ingredient": "Mercaptamine hydrochloride",
"supplier_code": "3371801000001103"
}See everything about mercaptamine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.